GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Phibro Animal Health Corp (FRA:PB8) » Definitions » Debt-to-Revenue

Phibro Animal Health (FRA:PB8) Debt-to-Revenue : 0.49 (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Phibro Animal Health Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Phibro Animal Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €13.9 Mil. Phibro Animal Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €447.3 Mil. Phibro Animal Health's annualized Revenue for the quarter that ended in Sep. 2024 was €938.6 Mil. Phibro Animal Health's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 0.49.


Phibro Animal Health Debt-to-Revenue Historical Data

The historical data trend for Phibro Animal Health's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phibro Animal Health Debt-to-Revenue Chart

Phibro Animal Health Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 0.51 0.50 0.52 0.52

Phibro Animal Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.51 0.50 0.48 0.49

Competitive Comparison of Phibro Animal Health's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phibro Animal Health's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Phibro Animal Health's Debt-to-Revenue falls into.



Phibro Animal Health Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Phibro Animal Health's Debt-to-Revenue for the fiscal year that ended in Jun. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(34.61 + 453.542) / 945.424
=0.52

Phibro Animal Health's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(13.873 + 447.335) / 938.596
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.


Phibro Animal Health Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Phibro Animal Health's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Phibro Animal Health Business Description

Traded in Other Exchanges
Address
300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, USA, 07666-6712
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Phibro Animal Health Headlines

No Headlines